Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate.
Nemergut, M., Marques, S.M., Uhrik, L., Vanova, T., Nezvedova, M., Gadara, D.C., Jha, D., Tulis, J., Novakova, V., Planas-Iglesias, J., Kunka, A., Legrand, A., Hribkova, H., Pospisilova, V., Sedmik, J., Raska, J., Prokop, Z., Damborsky, J., Bohaciakova, D., Spacil, Z., Hernychova, L., Bednar, D., Marek, M.(2023) Mol Neurodegener 18: 38-38
- PubMed: 37280636 
- DOI: https://doi.org/10.1186/s13024-023-00620-9
- Primary Citation of Related Structures:  
8AX8, 8AX9, 8CDY, 8CE0 - PubMed Abstract: 
Apolipoprotein E (ApoE) ε4 genotype is the most prevalent risk factor for late-onset Alzheimer's Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy is unknown.
Organizational Affiliation: 
Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.